BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 20484029)

  • 1. Inhibiting the cyclin-dependent kinase CDK5 blocks pancreatic cancer formation and progression through the suppression of Ras-Ral signaling.
    Feldmann G; Mishra A; Hong SM; Bisht S; Strock CJ; Ball DW; Goggins M; Maitra A; Nelkin BD
    Cancer Res; 2010 Jun; 70(11):4460-9. PubMed ID: 20484029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras.
    Eggers JP; Grandgenett PM; Collisson EC; Lewallen ME; Tremayne J; Singh PK; Swanson BJ; Andersen JM; Caffrey TC; High RR; Ouellette M; Hollingsworth MA
    Clin Cancer Res; 2011 Oct; 17(19):6140-50. PubMed ID: 21825040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-139 inhibits pancreatic-cancer carcinogenesis by suppressing RalB via the Ral/RAC/PI3K pathway.
    Wang Y; Zheng Y; Chen Q; Dai Y; Li T
    Arch Biochem Biophys; 2021 Jun; 704():108719. PubMed ID: 33290747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin-dependent kinase 5 mediates pleiotrophin-induced endothelial cell migration.
    Lampropoulou E; Logoviti I; Koutsioumpa M; Hatziapostolou M; Polytarchou C; Skandalis SS; Hellman U; Fousteris M; Nikolaropoulos S; Choleva E; Lamprou M; Skoura A; Megalooikonomou V; Papadimitriou E
    Sci Rep; 2018 Apr; 8(1):5893. PubMed ID: 29651006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models.
    Feldmann G; Mishra A; Bisht S; Karikari C; Garrido-Laguna I; Rasheed Z; Ottenhof NA; Dadon T; Alvarez H; Fendrich V; Rajeshkumar NV; Matsui W; Brossart P; Hidalgo M; Bannerji R; Maitra A; Nelkin BD
    Cancer Biol Ther; 2011 Oct; 12(7):598-609. PubMed ID: 21768779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the Ral and phosphatidylinositol 3' kinase signaling pathways by the ras-related protein TC21.
    Rosário M; Paterson HF; Marshall CJ
    Mol Cell Biol; 2001 Jun; 21(11):3750-62. PubMed ID: 11340168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ral GTPase down-regulation stabilizes and reactivates p53 to inhibit malignant transformation.
    Tecleab A; Zhang X; Sebti SM
    J Biol Chem; 2014 Nov; 289(45):31296-309. PubMed ID: 25210032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant overexpression of the Rgl2 Ral small GTPase-specific guanine nucleotide exchange factor promotes pancreatic cancer growth through Ral-dependent and Ral-independent mechanisms.
    Vigil D; Martin TD; Williams F; Yeh JJ; Campbell SL; Der CJ
    J Biol Chem; 2010 Nov; 285(45):34729-40. PubMed ID: 20801877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.
    Gysin S; Lee SH; Dean NM; McMahon M
    Cancer Res; 2005 Jun; 65(11):4870-80. PubMed ID: 15930308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the cyclin-dependent kinase 5 in metastatic melanoma.
    Sharma S; Zhang T; Michowski W; Rebecca VW; Xiao M; Ferretti R; Suski JM; Bronson RT; Paulo JA; Frederick D; Fassl A; Boland GM; Geng Y; Lees JA; Medema RH; Herlyn M; Gygi SP; Sicinski P
    Proc Natl Acad Sci U S A; 2020 Apr; 117(14):8001-8012. PubMed ID: 32193336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ras oncogene-independent activation of RALB signaling is a targetable mechanism of escape from NRAS(V12) oncogene addiction in acute myeloid leukemia.
    Pomeroy EJ; Lee LA; Lee RDW; Schirm DK; Temiz NA; Ma J; Gruber TA; Diaz-Flores E; Moriarity BS; Downing JR; Shannon KM; Largaespada DA; Eckfeldt CE
    Oncogene; 2017 Jun; 36(23):3263-3273. PubMed ID: 27991934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Inhibition of Cyclin-Dependent Kinases (Dinaciclib) and AKT (MK-2206) Blocks Pancreatic Tumor Growth and Metastases in Patient-Derived Xenograft Models.
    Hu C; Dadon T; Chenna V; Yabuuchi S; Bannerji R; Booher R; Strack P; Azad N; Nelkin BD; Maitra A
    Mol Cancer Ther; 2015 Jul; 14(7):1532-9. PubMed ID: 25931518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of Ras and Ral in chemotactic migration of skeletal myoblasts.
    Suzuki J; Yamazaki Y; Li G; Kaziro Y; Koide H
    Mol Cell Biol; 2000 Jul; 20(13):4658-65. PubMed ID: 10848592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ras-related small GTPases RalA and RalB regulate cellular survival after ionizing radiation.
    Kidd AR; Snider JL; Martin TD; Graboski SF; Der CJ; Cox AD
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):205-12. PubMed ID: 20619549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
    Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
    Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and characterization of small molecules that target the GTPase Ral.
    Yan C; Liu D; Li L; Wempe MF; Guin S; Khanna M; Meier J; Hoffman B; Owens C; Wysoczynski CL; Nitz MD; Knabe WE; Ahmed M; Brautigan DL; Paschal BM; Schwartz MA; Jones DN; Ross D; Meroueh SO; Theodorescu D
    Nature; 2014 Nov; 515(7527):443-7. PubMed ID: 25219851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin-dependent kinase 5 regulates endothelial cell migration and angiogenesis.
    Liebl J; Weitensteiner SB; Vereb G; Takács L; Fürst R; Vollmar AM; Zahler S
    J Biol Chem; 2010 Nov; 285(46):35932-43. PubMed ID: 20826806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ras inhibitors display an anti-metastatic effect by downregulation of lysyl oxidase through inhibition of the Ras-PI3K-Akt-HIF-1α pathway.
    Yoshikawa Y; Takano O; Kato I; Takahashi Y; Shima F; Kataoka T
    Cancer Lett; 2017 Dec; 410():82-91. PubMed ID: 28951129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDK5 positively regulates Notch1 signaling in pancreatic cancer cells by phosphorylation.
    Chu Q; Wang L; Zhang J; Wang W; Wang Y
    Cancer Med; 2021 Jun; 10(11):3689-3699. PubMed ID: 33960694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential involvement of RalA and RalB in colorectal cancer.
    Martin TD; Der CJ
    Small GTPases; 2012; 3(2):126-30. PubMed ID: 22790202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.